“Reprogramming the Brain Immune System for the Treatment of GBM: Initial Results from a First-in-Human Phase I Clinical Trial”

Pedro Lowenstein, MD, PhD
Professor, Neurosurgery, Cell and
Developmental Biology,
Richard C. Schneider Collegiate
University of Michigan Medical School

For any inquires, please contact Madoka Morris at mmorris19@bwh.harvard.edu 

Direction to Hale Conference Room:
Enter at 60 Fenwood Rd lobby. Take the S elevators to the 3rd floor. Once on the 3rd floor, take a right at the corridor and the room will be on your right through the glass doors.